How many stem-cell trials for Parkinson's Disease are recruiting right now?
The registry lists 15 studies actively recruiting out of 71 records in total (21%), as of 2026-08-29.
Who these studies will actually take
Graft trials require confirmed idiopathic disease, levodopa responsiveness, a disability band and tolerance of immunosuppression and neurosurgery. Atypical parkinsonian syndromes are excluded, and misdiagnosis is common enough that screening rejects a real share of applicants.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT02795052 — Neurologic Stem Cell Treatment Study | n/a | Recruiting | 500 | MD Stem Cells | 2016-06 |
| NCT06944522 — A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease | Phase 3 | Recruiting | 102 | BlueRock Therapeutics | 2025-06-17 |
| NCT06145711 — A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells | n/a | Recruiting | 3 | Shanghai East Hospital | 2023-11-23 |
| NCT06167681 — The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease | Phase 1, Phase 2 | Recruiting | 40 | iRegene Therapeutics Co., Ltd. | 2024-01-17 |
| NCT06482268 — Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) | Phase 1 | Recruiting | 7 | University of California, San Diego | 2024-06-01 |
| NCT05152394 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease | Phase 1 | Recruiting | 20 | The Foundation for Orthopaedics and Regenerative Medicine | 2024-08-17 |
| NCT07080775 — The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease | Phase 1 | Recruiting | 12 | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 2025-08-05 |
| NCT06687837 — Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons | Phase 1 | Recruiting | 8 | Jeffrey S. Schweitzer, MD, PhD | 2025-04-29 |
What recruiting does and does not mean
A recruiting flag says a protocol cleared ethics review and enrolment is open. It says nothing about earlier results, nothing about your eligibility and nothing about price, because trials are not a purchase channel. Stale flags are common, so contact the listed coordinator rather than trusting the status field.
Sites sit in 21 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- iRegene Therapeutics Co., Ltd. — 5 registered records
- Shanghai East Hospital — 4 registered records
- Hope Biosciences Research Foundation — 4 registered records
- BlueRock Therapeutics — 3 registered records
- MD Stem Cells — 2 registered records
- S.Biomedics Co., Ltd. — 2 registered records
Frequently asked
How many stem-cell trials for Parkinson's Disease are recruiting right now?
15 of 71 registered records (2026-08-29).
Can I join one of these trials?
Eligibility is decided by the protocol, not by willingness to pay. Read the inclusion and exclusion list on the registry record, then contact the coordinator named there.
Do trials charge participants?
Standard practice is that the sponsor funds the investigational product. Charges framed as administrative fees deserve the same scrutiny as the treatment claim itself.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Parkinson's Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Parkinson's Disease cost? (2026)
- Parkinson's Disease stem cell therapy — your questions answered (2026)
- Parkinson's Disease: cell-therapy evidence by therapy class
- MSC vs exosomes for Parkinson's Disease: what the registries show